CurrentRheuma
Get Weekly

CurrentRheuma coverage · page 10 of 22

Clinical and Experimental Rheumatology

Briefs 361–400 of 849 CurrentRheuma has covered from this journal, newest publication first

Latest from Clinical and Experimental Rheumatology

All coverage, newest first

  1. Clin Exp Rheumatol

    Fibroblast activities are associated with prolonged QTc and pulmonary arterial hypertension in patients with systemic sclerosis

    Cross-sectional studySystemic sclerosis

  2. Clin Exp Rheumatol

    Tumour necrosis factor-like weak inducer of apoptosis participates in the development of cutaneous fibrosis in an experimental systemic sclerosis model

    Mechanistic studySystemic sclerosis

  3. Clin Exp Rheumatol

    Assessing the efficacy of anticoagulation therapy in the treatment of vascular Behçet's disease: a systematic review

    Meta-analysisVasculitis & PMR

  4. Clin Exp Rheumatol

    The burden of illness of the organ manifestations of systemic sclerosis: a pragmatic, targeted review

    Research articleSystemic sclerosis

  5. Clin Exp Rheumatol

    C-reactive protein thresholds for discriminating active disease in axial spondyloarthritis: should we lower them?

    Diagnostic or prognostic studySpondyloarthritis & PsA

  6. Clin Exp Rheumatol

    Investigating the trajectory of functional disability in systemic sclerosis: group-based trajectory modelling of the Health Assessment Questionnaire-Disability Index

    Cohort studySystemic sclerosis

  7. Clin Exp Rheumatol

    Comparison of serum exosome miRNA from patients with Raynaud's phenomenon with positive and negative serum antinuclear antibodies

    Cross-sectional studySystemic sclerosis

  8. Clin Exp Rheumatol

    Impact of time to diagnosis in patients with primary Sjögren's syndrome: a cross-sectional study

    Cross-sectional studySjögren's & overlap

  9. Clin Exp Rheumatol

    Effect of TNF-α blockers on reducing the risk of dementia in rheumatoid arthritis: a nationwide cohort study

    Cohort studyRA

  10. Clin Exp Rheumatol

    The association between radiographic progression, functional impairment, markers of dyslipidaemia and inflammation in patients with hand osteoarthritis: a five-year longitudinal study

    Cohort studyOsteoarthritis

  11. Clin Exp Rheumatol

    Primary versus systemic-sclerosis-associated Raynaud's phenomenon: relationship with clinical and environmental factors

    Case-control studySystemic sclerosis

  12. Clin Exp Rheumatol

    The comparison of clinical and pathological features between patients of SAPHO syndrome with different microbiological findings in bone biopsy

    Cross-sectional studyAutoinflammatory & rare

  13. Clin Exp Rheumatol

    Efficacy of N-acetylcysteine for treating dryness symptoms of Sjögren's disease: randomised placebo-controlled double-blind clinical study

    Randomized controlled trialSjögren's & overlap

  14. Clin Exp Rheumatol

    Ultrasound for day-to-day clinical use: construction of a simple discriminator between healthy skin and thickened systemic sclerosis skin

    Cross-sectional studySystemic sclerosis

  15. Clin Exp Rheumatol

    Occupational, smoking and biomass fuel exposure in a cohort of Mexican patients with IgG4-related disease.

    Cross-sectional studyAutoinflammatory & rare

  16. Clin Exp Rheumatol

    High prevalence of orofacial pain in juvenile fibromyalgia as detected by a novel tool specifically devised for children and adolescents

    Cross-sectional studyPediatric

  17. Clin Exp Rheumatol

    Efficacy of physiotherapy treatment in medium and long term in adults with fibromyalgia: an umbrella of systematic reviews

    Research articleFibromyalgia & pain

  18. Clin Exp Rheumatol

    Beyond pain: the influence of psychological factors on functional status in fibromyalgia

    Cross-sectional studyFibromyalgia & pain

  19. Clin Exp Rheumatol

    Delay in fibromyalgia diagnosis and its impact on the severity and outcome: a large cohort study

    Cohort studyFibromyalgia & pain

  20. Clin Exp Rheumatol

    Serum Wnt3A levels are significantly associated with cross-sectional vasculitis activity and end-stage kidney disease during follow-up of patients with antineutrophil cytoplasmic antibody-associated vasculitis

    Cohort studyVasculitis & PMR

  21. Clin Exp Rheumatol

    The expression of Siglec-10 on naive B cells is involved in the pathology of systemic lupus erythematosus

    Mechanistic studyLupus & APS

  22. Clin Exp Rheumatol

    Identification of two autoantigens recognised by circulating autoantibodies as potential biomarkers for diagnosing giant cell arteritis

    Diagnostic or prognostic studyVasculitis & PMR

  23. Clin Exp Rheumatol

    Cluster analysis identifies the differential impact of disease activity and severity on functional status and patient satisfaction in rheumatoid arthritis: the FRANK registry

    Cross-sectional studyRA

  24. Clin Exp Rheumatol

    Impact of a clinical pharmacist consultation on enhancing knowledge and safety skills in patients with chronic inflammatory arthritis treated with bDMARDs

    Cohort studyRA

  25. Clin Exp Rheumatol

    Human epididymitis protein 4 as a biomarker of interstitial lung disease in patients with idiopathic inflammatory myopathies

    Cross-sectional studyMyositis

  26. Clin Exp Rheumatol

    Mapping in healthy subjects different body areas for dermal thickness and skin hardness by high frequency ultrasound and durometry

    Cross-sectional studySystemic sclerosis

  27. Clin Exp Rheumatol

    Assessing IgG4-related autoimmune pancreatitis with contrast-enhanced ultrasonography based on time-intensity curve: a single-centre prospective study

    Cohort studyAutoinflammatory & rare

  28. Clin Exp Rheumatol

    Reduced Deltex1 expression in T cells indicates increased disease activity in Sjögren's disease

    Cross-sectional studySjögren's & overlap

  29. Clin Exp Rheumatol

    CCR4+Tfh2 cells specifically produce IL-4 driving the pathological reaction in IgG4-related disease

    Mechanistic studyAutoinflammatory & rare

  30. Clin Exp Rheumatol

    Rheumatoid arthritis-associated interstitial lung disease: clinical characteristics and mortality in a large single-centre cohort

    Cohort studyRA

  31. Clin Exp Rheumatol

    Different giant cell arteritis phenotypes may present distinct types of ischaemic complications

    Cohort studyVasculitis & PMR

  32. Clin Exp Rheumatol

    Granzyme B producing regulatory B-cells in patients with giant cell arteritis

    Mechanistic studyVasculitis & PMR

  33. Clin Exp Rheumatol

    Integrated analysis of genome-wide copy number variation and exome-wide rare variation identified novel loci for rheumatoid arthritis

    Research articleRA

  34. Clin Exp Rheumatol

    Cost-utility of tofacitinib in the treatment of moderate-to-severe rheumatoid arthritis in France: a multi-state Markov model analysis

    Cohort studyRA

  35. Clin Exp Rheumatol

    Risk prediction modelling in idiopathic inflammatory myositis-associated interstitial lung disease based on seven factors including serum KL-6 and lung ultrasound B-lines

    Cohort studyMyositis

  36. Clin Exp Rheumatol

    Triple-combination therapy did not improve prognosis in anti-MDA5 positive dermatomyositis: a multicentre longitudinal cohort study

    Cohort studyMyositis

  37. Clin Exp Rheumatol

    A proposed clinical tool to identify high-risk patients for monogenic lupus: a pilot study

    Diagnostic or prognostic studyPediatric

  38. Clin Exp Rheumatol

    Th1/Th2 associated transcription factors and cytokines in pregnancies with systemic lupus erythematosus

    Case-control studyLupus & APS

  39. Clin Exp Rheumatol

    Convergence and divergence in Kawasaki disease and multisystem inflammatory syndrome in children: results from the COVASAKI survey

    Cohort studyPediatric

  40. Clin Exp Rheumatol

    A charter to improve care for systemic lupus erythematosus

    Guideline or statementLupus & APS

All 849 Briefs in ExploreShowing Briefs 361–400 of 849, newest first